BU-NOT-SET

CONTACT US
Advanced Bio is advancing rAAV production
  • Biologics
  • Manufacturing
Recipharm_Advanced_Bio_Virus
White paper
Advanced Bio Is advancing LNP formulation
  • Biologics
  • Manufacturing
Recipharm_AdvancedBio_RNA
White paper
Optimising drug formulation: The critical role of granulation
  • Drug product
  • Manufacturing
powder
White paper
Overcoming fixed-dose combination challenges for ALS
  • Drug product
  • Manufacturing
Recipharm_API
Case study
What’s shaping the future of pharma?
  • Industry trends
Vials
Video
Mastering tech-transfer: Turning complexity into competitive advantage
  • Drug product
  • Manufacturing
ReciPredict_people in a z
Insight
Four ways ReciPredict can transform your pharma manufacturing
  • Drug product
  • Manufacturing
logo
Insight
An expert’s guide to analytical services
  • Analytical chemistry
  • Industry trends
people in a lab
Insight
How lyophilisation can help overcome mRNA stability challenges
  • Drug product
  • Manufacturing
jars
Insight
Case study
  • Drug product
Optimising formulation to improve solubility ready for Phase III
Insight
  • Drug product
  • Industry trends
Trends emerging in capsule dosage form development
Fact sheet
  • Corporate
Licensing portfolio
Insight
  • Industry trends
Key trends in pharmaceutical outsourcing
Insight
  • Drug product
  • Industry trends
The latest trends and innovations in oral drug delivery
Insight
  • Corporate
Recipharm invests in African vaccine production
Insight
  • Drug product
  • Industry trends
The future of oral solid dose development and manufacturing
Report
  • Sustainability
Sustainability Report 2021
Insight
  • Corporate
Treating long-COVID with Erdosteine